Lipoprotein-associated phospholipase A2 is especially predictive of coronary artery disease among patients with the metabolic syndrome

被引：0
|
作者：
Lavasani, Farangis
May, Heidi T.
Horne, Benjamin D.
Anderson, Jeffrey L.
Carlquist, John F.
Wolfert, Robert L.
Pearson, Robert R.
Lanman, Richard B.
Muhlestein, Joseph B.
机构：
[1] LDS Hosp, Salt Lake City, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339A / 339A
页数：1
相关论文
共 50 条
  • [31] Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
    Mourouzis, Konstantinos
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Tsigkou, Vicky
    Antonopoulos, Alexis
    Bletsa, Evanthia
    Stampouloglou, Panagiota
    Vlasis, Konstantinos
    Vavuranakis, Manolis
    Tousoulis, Dimitris
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [32] Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
    Mourouzis, K.
    Siasos, G.
    Oikonomou, E.
    Zaromitidou, M.
    Tsigkou, V
    Antonopoulos, A. S.
    Bletsa, E.
    Stampouloglou, P. K.
    Vlassis, K.
    Vavouranakis, M.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1264 - 1264
  • [33] Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease
    Maiolino, Giuseppe
    Lenzini, Livia
    Pedon, Luigi
    Cesari, Maurizio
    Seccia, Teresa Maria
    Frigo, Anna Chiara
    Rossitto, Giacomo
    Caroccia, Brasilina
    Rossi, Gian Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (01) : 29 - 36
  • [34] Lipoprotein-associated phospholipase A2
    McConnell, Joseph P.
    Hoefner, Daniel M.
    CLINICS IN LABORATORY MEDICINE, 2006, 26 (03) : 679 - +
  • [35] The correlation between lipoprotein-associated phospholipase A2 and severity of coronary artery diseases
    黄立纲
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (03) : 159 - 159
  • [36] Predictive Value of Serum Lipoprotein-Associated Phospholipase A2 for Type 2 Diabetes Mellitus Complicated with Metabolic Syndrome in Elderly Patients
    Ren, Junhong
    Chang, Minjing
    Song, Shan
    Zhao, Rong
    Xing, Xiaolong
    Chang, Xinjian
    CLINICAL LABORATORY, 2022, 68 (08) : 1636 - 1642
  • [37] Lipoprotein-associated phospholipase A2 is associated with angiographic coronary artery disease on univariate analysis but loses independent predictive value in a multivariate model
    Brilakis, ES
    McConnell, JP
    Lennon, RJ
    Meyer, JG
    Berger, PB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 283A - 283A
  • [38] Lipoprotein-associated phospholipase A2 is associated with coronary artery calcification in men with a family history of premature coronary heart disease
    Wolfe, ML
    Dada, N
    Suckling, KE
    Spurr, NK
    Campbell, DA
    Macphea, CH
    Rader, DJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A56 - A56
  • [39] Different associations of lipoprotein-associated phospholipase A2 and coronary artery calcification among American and Japanese men
    El-Saed, A
    Sekikawa, A
    Ueshima, H
    Zaky, RW
    Kadowaki, T
    Okamura, T
    Kita, Y
    Edmundowics, D
    Nakamura, Y
    Kuller, LH
    CIRCULATION, 2006, 113 (08) : E366 - E366
  • [40] Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease
    Riley, Robert F.
    Corson, Marshall A.
    IDRUGS, 2009, 12 (10) : 648 - 655
12345